An Introduction to Ocular Oncology
Advanced research into genetics and cancer has revolutionised our understanding of conjunctival and uveal melanoma, but treatment remains challenging.
Browse the content below, to see leading experts discuss the latest data in video interviews and short articles from our conference hub. You can also view the selection of peer-reviewed articles from our journals. If you’re looking to learn more about the impact of these developments on patient outcomes, our educational activities are a great resource.
Ocular Oncology Content
Radiation Retinopathy—A Review of Past and Current Treatment Strategies
US Ophthalmic Review. 2020;13(1):34–9 DOI: https://doi.org/10.17925/USOR.2020.13.1.34
Radiation retinopathy is a common and slowly progressive visual side effect of radiation therapy, such as brachytherapy, external beam radiotherapy, proton beam radiation, helium ion radiotherapy, and gamma knife radiotherapy for uveal melanoma and other intraocular or orbital cancers.1–6 Patients treated with radiation therapy for cancers of the head and neck can also develop radiation-related […]
Antonia Joussen, EURETINA 2019 – Treating patients with large tumours
Antonia Joussen (Charité, University Medicine Berlin) shares her advice on preserving the eye when treating patients with large tumours and shares the key take-home messages of her presentations at EURETINA 2019. Questions: 1. How do you preserve eyes with large tumours? 2. What are the main take-home messages of your presentations at EURETINA 2019? Support: […]
SOE 2017 – Bertil Damato Keynote Lecture
Bertil Damato presents the Keynote lecture ” Diagnosis and Treatment of Uveal Melanoma: A New Millennium” at SOE 2017.
Immunoembolization and Ipilmumab to treat Uveal Melanoma
Marlana Orloff, MD of Thomas Jeffereson University discusses the recent use of immunoembolization and ipilmumab to treat uveal melanoma.
Dr Mark Middleton, (University of Oxford, Oxford, UK) talks to ecancertv at AACR 2015 about how a first-in-class immunotherapy called IMCgp100 yielded durable responses in patients with advanced cutaneous melanoma and those with advanced ocular melanoma.
Uveal Melanomas After Tumor Necrosis Factor-α Inhibitors
Dr. Jose Pulido, a professor of ophthalmology and molecular medicine at Mayo Clinic in Rochester, MN, expresses concern in his article appearing in the November 2014 issue of Mayo Clinic proceedings for patients who have coroidal nevi (3% of the general population) and who are being prescribed tumor Necrosis Factor-α Inhibitors. Until more is known, […]
Intraocular tumor Surgery, Melanoma
Melanomas (choroidal, ciliary body and uveal) -Early stages has no symptoms (the person does not know there is a tumor until an ophthalmology examination). As the tumor grows, symptoms can be blurred vision, decreased vision, double vision, eventual vision loss and if they continue to grow the tumor can break past the retina causing retinal […]
DR. AMIT ARORA – OCUMEL UK CONFERENCE 2014
The 2014 conference was held at the North West Cancer Research Centre (NWCR) – at the University of Liverpool, close to the Ocular Oncology Centre on Friday 19th September 2014.
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!